The Wall Street Journal: Pfizer working on freeze-dried version of COVID-19 vaccine that doesn’t need ultracold storage


Pfizer Inc. and partner BioNTech SE plan to begin soon testing a freeze-dried version of its COVID-19 vaccine, which if proven to work safely could ease storage and handling of the shots in rural U.S. areas and low-income countries.

Market Extra: Wall Street bet on financing self-employed home buyers. Will there be regrets?

Previous article

Dispatches from a Pandemic: What you need to know about COVID-19 vaccine passports — and the ‘double privilege’ dilemma they raise for society

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News